Background: Q-switched (QS) lasers, which include the potassium titanyl phosphate (KTP) 532nm neodymium-yttriumaluminium garnet (Nd:YAG), alexandrite, and ruby lasers, have been proven effective in the treatment of benign pigmented lesions for the past 20 years. The purpose of this study was to evaluate the efficacy and safety of a 532 nm KTP laser device for the treatment of pigmented lesions on the face and neck.Methods: Fifteen healthy male and female patients with visible pigmented lesions of the face and neck were treated with a fractional, non-ablative, Q-switched 532-nm Nd:YAG laser device. Treatment was performed in a single session, and all patients were followed for three months after treatment. Efficacy was rated by the physician using the Global Aesthetic Improvement Scale (GAIS) and by patients using a Likert scale, both ranging from 1 (low efficacy) to 5 (high efficacy). Adverse events and patient-reported pain were monitored.
Results:The mean GAIS score was 4.2 ± 0.5 and patient satisfaction was 4.3 ± 0.4, with no significant difference (t-test =0.55, α=0.05) and a strong positive correlation between these measures (r=0.91). On a scale of 1-10, mean pain was 3.2 ± 0.9 and the only minor side effect was crusting for up to 7 days after treatment, which was expected.
Conclusion:The Q-switched Nd:YAG laser used in this study was found to be safe and effective for the treatment of facial pigmented lesions.